Insider trading activity reported at Entrada Therapeutics and Millrose Properties

Recent SEC filings reveal significant insider trading activity at Entrada Therapeutics and Millrose Properties.

At Entrada Therapeutics (NASDAQ:TRDA), Director Kush Parmar has executed multiple stock sales throughout July and August. Most recently, on August 6, Parmar sold 10,494 shares at an average price of $7.00. This follows several other transactions, including a sale of 92,444 shares on August 10 and 52,317 shares on August 7. Following these sales, Parmar maintains a position of approximately 2,836,098 shares.

In contrast, Millrose Properties (NYSE:MRP) saw insider buying from Director Carlos Migoya. On August 7, Migoya purchased 1,000 shares at an average cost of $29.18 per share, totaling $29,180. This acquisition increased his direct ownership in the company by 3.44%, bringing his total holdings to 30,075 shares.